Across TCGA pan-cancer cohorts, SPAG11B RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SPAG11B’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where SPAG11B RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SPAG11B is over-expressed in tumor.
LUSC and THCA are the cancer types where SPAG11B tumor–normal differential expression is most reproducible.